These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2887147)

  • 1. [Relation between arterial hypertension and plasma lipoproteins: the Australian experience].
    MacDonald GJ
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():29-32. PubMed ID: 2887147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP; Hill P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study.
    MacMahon SW; Macdonald GJ; Blacket RB
    Arteriosclerosis; 1985; 5(4):391-6. PubMed ID: 4015511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between antihypertensive drug therapies and plasma lipid levels in the general population.
    Maitland-van der Zee AH; Klungel OH; Kloosterman JM; Seidell JC; Leufkens HG; de Boer A
    J Hum Hypertens; 2001 Oct; 15(10):701-5. PubMed ID: 11607800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses].
    Rouffy J
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():43-6. PubMed ID: 2887148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension, antihypertensive drugs, and atherogenesis. Mechanisms and clinical implications.
    Chobanian AV
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):148S-157S. PubMed ID: 2878982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J; Chanu B; Bakir R; Sauvanet JP
    J Pharmacol; 1983; 14 Suppl 2():183-99. PubMed ID: 6138467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E; Velasco M; Silva H; Camejo G
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline values. II: Variations in plasma lipoprotein fractions during doxazosin treatment for hypertension.
    Ahaneku JE; Taylor GO; Agbedana EO
    Int J Clin Pharmacol Res; 1998; 18(4):165-70. PubMed ID: 10052026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T; Kitazawa Y; Noma A; Maeda S; Kato A; Ando Y; Ido T; Inazumi K; Hayakawa T; Goto Y; Ichien M
    J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood lipids profile in obese or overweight patients.
    Szczygielska A; Widomska S; Jaraszkiewicz M; Knera P; Muc K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):343-9. PubMed ID: 15323217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study.
    MacMahon SW; Macdonald GJ
    Am J Med; 1986 Feb; 80(2A):40-7. PubMed ID: 3946460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.